BUSINESSBLOOMBERG
Ascend Sport Said to Mull Listing in Up to $740 Million Merger
Switzerland’s Ascend Sport Technology AG is exploring strategic options, including a reverse merger with a listed shell company. This potential listing could value the firm between 500 million and 600 million Swiss francs, which translates to $740 million.
Mentioned
Related Signal
Adjacent reporting
- AstraZeneca stock sinks on reports of merger talks with Bristol Myers Squibb
- AstraZeneca holds talks with Bristol Myers Squibb on $400bn merger
- AstraZeneca holds talks with Bristol Myers Squibb over £300bn merger
- FirstFT: AstraZeneca and Bristol Myers Squibb discuss $400bn tie-up
- AstraZeneca holds talks with Bristol Myers Squibb on $400bn merger
- AstraZeneca investors raise concerns over mega-merger talks